Febiven
| Febiven | |
|---|---|
| Fabian Diepstraten | |
| Born | September 23, 1996 (age 19) |
| Nationality | Dutch |
| Current team | fnatic |
| Role | Mid laner |
| League | EU LCS |
| Games | League of Legends |
| Championships | 2015 EU LCS Spring, 2015 EU LCS Summer |
| Professional career | |
| Jan 2014 - May 2014 | Cloud 9 Eclipse |
| May 2014 - Jan 2015 | H2k-Gaming |
| Jan 2015 - Dec 2016 | Fnatic |
| Dec 2016 - present | H2K-Gaming |
Fabian Diepstraten, known as Febiven is the mid laner of team Fnatic of the EU LCS, and is currently known as one of the strongest mid laners in the EU LCS.[1]
Career
Febiven first joined Cloud 9 Eclipse in January 2014, and this was the start of his eSports career. The team failed to qualify for the EU LCS, however during that time Febiven had attracted the attention of several large organisations. In May 2014, Febiven left Cloud 9 Eclipse to join team H2k-Gaming.
On January 7, 2015, H2k-Gaming announced Febiven's departure. He then joined the reinvented team of Fnatic and his performance increased drastically. With a 7.8 KDA and first place in the EU LCS Championships, he has become one of the best-known mid laners in Europe.
Currently Febiven is residing in a gaming apartment in Berlin, Germany with his fellow Fnatic team members.
On June 23, 2016 he and teammate Rekkles broke the creep score (CS) world record with 858 minions killed in a game.[2]
Personal life
He comes from a family of six, and was born on September 23, 1996 in the Netherlands. Febiven started gaming at home with his two brothers, and they always played in the attic as their computer was placed there. His gaming career started when one day, he received a call from the United States with an offer to sign a contract.
He was in cover of Vogue Netherlands[3]
Tournaments results
Fnatic
- 1st — 2015 EU LCS Spring
- 3-4th — 2015 Mid-Season Invitational
- 1st — 2015 EU LCS Summer
- 3-4th — 2015 World Championship
- 3-4th — IEM X Cologne
- 3rd — 2016 EU LCS Spring playoffs
- 2nd — IEM X World Championship
References
As of this edit, this article uses content from "Febiven", which is licensed in a way that permits reuse under the Creative Commons Attribution-ShareAlike 3.0 Unported License, but not under the GFDL. All relevant terms must be followed.